TB, Tumor & Cancer Drugs

TB, Tumor & Cancer Drugs

Global B2B Supply for Oncology and TB Treatment

Pharmint is your trusted sourcing partner for TB, Tumor & Cancer Drugs, supplying GMP-certified active ingredients, formulations, and research-use compounds across Africa, LATAM, the Middle East, and Asia.

We serve procurement teams from hospitals, research centers, oncology distributors, and public health initiatives seeking quality-assured drugs for TB, solid tumors, and co-treatment protocols.

With growing health burdens in emerging regions, we help institutions access premium TB, Tumor & Cancer Drugs in bulk, supported by COA/MSDS, cold-chain logistics, and regulatory documentation. From Invista 100mg Tablets (Dasatinib) to Fenbendazole 500 Mg and WHO-standard anti-TB APIs, our catalog bridges clinical need with global pharma supply.

What Are TB, Tumor & Cancer Drugs?

These are pharmacological agents used in the treatment of:

• Pulmonary tuberculosis (TB) – including resistant strains
• Cancerous tumors – including non-small cell lung cancer, leukemia, breast and liver cancer
• Co-infections – enabling dual therapies where TB and cancer overlap

Products include immune checkpoint inhibitors, tyrosine kinase inhibitors, cytotoxic agents, and standard TB APIs like isoniazid, rifampicin, and linezolid. They are used in clinical settings, R&D, and therapeutic regimens across oncology and infectious disease sectors.

Who We Serve Across Asia, LATAM, Africa & the Middle East?

Pharmint supports institutional buyers such as:

• Government TB programs and tender committees
• Cancer treatment centers and hospitals
• Oncology-focused distributors
• Research organizations studying tumor pathways and TB immunology
• Veterinary oncology research units using products like Fenbendazole 500 Mg

We specialize in regional procurement from India, UAE, Saudi Arabia, Egypt, Kenya, Nigeria, Brazil, Colombia, Mexico, Bangladesh, and more.

Featured Products for TB and Oncology Treatment

• Anti-TB APIs & Formulations

Isoniazid • Rifampicin • Levofloxacin • Ethambutol • Linezolid •Pyrazinamide

• Oncology & Tumor Drugs
  

Dasatinib Tablets • Osimertinib • Sorafenib • Gefitinib • Trastuzumab • Paclitaxel •Carboplatin

• Veterinary & Research Support

Fenbendazole – Investigated for anti-tumor properties in non-human trials

Why Choose Pharmint for TB & Tumor Drug Procurement?

• GMP-certified and WHO-aligned supply chain
• MOQs tailored for clinical or research buyers
• Full support with end-use declarations, import permits, and COA/MSDS documentation
• Cold-chain ready shipping for temperature-sensitive oncology products
• Flexible logistics across Africa, Middle East, LATAM, and South Asia
• Transparency in pricing, batch traceability, and export compliance

Regulatory-Compliant Global Shipping and Documentation

We streamline sourcing by offering ready documentation, real-time compliance updates, and global distribution for:

• TB treatment tenders
• Oncology therapeutic pipelines
• Clinical trial drug supplies
• Pharma export programs with MDR-TB and cancer control focus

Our ecosystem enables secure, documented movement of critical therapies—from active TB APIs to advanced tumor biologics—with a focus on emerging market access.

TB and Oncology FAQs 

What types of TB and cancer drugs does Pharmint supply?

We offer GMP-grade APIs and finished formulations for TB (e.g., rifampicin, linezolid) and cancer (e.g., Dasatinib, Trastuzumab, Sorafenib), including co-treatment options.

Do you support shipping to Africa, LATAM, or Middle East?

Yes. We export to all licensed buyers in these regions with COA, MSDS, and regulatory documentation included.

Are these products WHO-GMP certified?

Yes. Our inventory is sourced from GMP-certified facilities and aligned with WHO prequalification where applicable.

What is the minimum order quantity (MOQ)?

MOQ varies by product but we offer flexible quantities for clinical, institutional, or research-based buyers.

Are temperature-sensitive tumor drugs shipped under cold-chain?

Yes. We use validated packaging and tracking to maintain 2–8 °C storage compliance for biologics and immunotherapy agents.